04/08/2026 17:18
|
Medical, Health & Aged Care
SAN DIEGO--BUSINESS WIRE--
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive...